Moderna Inc (MRNA)
38.26
+1.32
(+3.57%)
USD |
NASDAQ |
Nov 21, 16:00
38.21
-0.05
(-0.13%)
After-Hours: 20:00
Moderna Total Assets (Quarterly): 15.80B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 15.80B |
| June 30, 2024 | 15.68B |
| March 31, 2024 | 16.73B |
| December 31, 2023 | 18.43B |
| September 30, 2023 | 19.45B |
| June 30, 2023 | 21.88B |
| March 31, 2023 | 24.12B |
| December 31, 2022 | 25.86B |
| September 30, 2022 | 26.06B |
| June 30, 2022 | 26.04B |
| March 31, 2022 | 27.61B |
| December 31, 2021 | 24.67B |
| September 30, 2021 | 20.92B |
| Date | Value |
|---|---|
| June 30, 2021 | 16.15B |
| March 31, 2021 | 12.69B |
| December 31, 2020 | 7.337B |
| September 30, 2020 | 4.651B |
| June 30, 2020 | 3.486B |
| March 31, 2020 | 2.068B |
| December 31, 2019 | 1.589B |
| September 30, 2019 | 1.591B |
| June 30, 2019 | 1.685B |
| March 31, 2019 | 1.806B |
| December 31, 2018 | 1.962B |
| September 30, 2018 | 1.489B |
| December 31, 2017 | 1.084B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.589B
Minimum
Dec 2019
27.61B
Maximum
Mar 2022
16.56B
Average
17.58B
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| Merck & Co Inc | 117.53B |
| Pfizer Inc | 219.48B |
| Novavax Inc | 1.712B |
| Vertex Pharmaceuticals Inc | 22.24B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.876B |
| Shareholders Equity (Quarterly) | 11.93B |
| Current Ratio | 4.392 |